| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 47 |
| 1 | INFLIXIMAB | 42 |
| 2 | INFLIXIMAB-DYYB | 24 |
| 3 | RISANKIZUMAB-RZAA | 22 |
| 4 | UPADACITINIB | 16 |
| 5 | AZATHIOPRINE | 15 |
| 6 | ACETAMINOPHEN | 13 |
| 7 | FUROSEMIDE | 12 |
| 8 | METHOTREXATE SODIUM | 10 |
| 9 | WARFARIN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 24 | 0.0070 |
| 1 | MENTHOL, METHYL SALICYLATE | 1 | 0.0017 |
| 2 | RESLIZUMAB | 1 | 0.0015 |
| 3 | ADALIMUMAB-RYVK | 1 | 0.0009 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 6 | NARATRIPTAN | 1 | 0.0007 |
| 7 | MINERAL OIL | 1 | 0.0007 |
| 8 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| 9 | FLURBIPROFEN | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 44 |
| 1 | Corticosteroid [EPC] | 19 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 3 | Benzodiazepine [EPC] | 16 |
| 4 | Janus Kinase Inhibitor [EPC] | 16 |
| 5 | Endothelin Receptor Antagonist [EPC] | 15 |
| 6 | Purine Antimetabolite [EPC] | 15 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | Vitamin C [EPC] | 10 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 2 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 5 | Purine Antimetabolite [EPC] | 15 | 0.0002 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |